Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FPKWG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,336
Award facts
- Contract value 100% obligated
- $28,336.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $28,336.29 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
Trelegy Ellipta is a combination inhalation medication used in respiratory treatment, reflecting DLA's ongoing pharmaceutical procurement to support military and federal healthcare systems. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical supply chains, providing brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency and other government healthcare customers. The firm fixed pricing structure and short completion timeline are typical of routine delivery orders under DLA's pharmaceutical prime vendor agreements, which enable rapid fulfillment of medical supply requirements across the federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FPKWG?
SPE2DB25FPKWG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FPKWG worth?
The government has obligated $28,336 on SPE2DB25FPKWG.
Is contract SPE2DB25FPKWG an order under another contract?
Yes. SPE2DB25FPKWG is a delivery order under SPE2DB25D3109, an indefinite delivery contract.
Was contract SPE2DB25FPKWG competed?
The extent of competition for SPE2DB25FPKWG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award